Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
2000.
Current Awareness.
Pharmacoepidemiology and Drug Safety,
Vol. 9,
Issue. 4,
p.
341.
Henshaw, Carol
2000.
Clinical and biological aspects of postpartum blues and depression.
Current Opinion in Psychiatry,
Vol. 13,
Issue. 6,
p.
635.
Simpson, Kerryn
and
Noble, Stuart
2000.
Fluoxetine.
CNS Drugs,
Vol. 14,
Issue. 4,
p.
301.
Thorpe, Lilian
Whitney, Diane K
Kutcher, Stanley P
and
Kennedy, Sidney H
2001.
Clinical Guidelines for the Treatment of Depressive Disorders VI. Special Populations.
The Canadian Journal of Psychiatry,
Vol. 46,
Issue. 1_suppl,
p.
63S.
Koren, Gideon
2002.
SSRIs in Pregnancy –Are they safe?.
Pediatric Research,
Vol. 51,
Issue. 4,
p.
424.
Heikkinen, Tuija
Ekblad, Ulla
and
Laine, Kari
2002.
Transplacental transfer of citalopram, fluoxetine and their primary demethylated metabolites in isolated perfused human placenta.
BJOG: An International Journal of Obstetrics & Gynaecology,
Vol. 109,
Issue. 9,
p.
1003.
Yonkers, Kimberly A
and
Pearlstein, Teri
2002.
Review of fluoxetine and its clinical applications in premenstrual dysphoric disorder.
Expert Opinion on Pharmacotherapy,
Vol. 3,
Issue. 7,
p.
979.
Simon, Gregory E.
Cunningham, Michael L.
and
Davis, Robert L.
2002.
Outcomes of Prenatal Antidepressant Exposure.
American Journal of Psychiatry,
Vol. 159,
Issue. 12,
p.
2055.
Hendrick, Victoria
and
Altshuler, Lori
2002.
Management of Major Depression During Pregnancy.
American Journal of Psychiatry,
Vol. 159,
Issue. 10,
p.
1667.
Morrison, Janna Leigh
Chien, Caly
Riggs, Kenneth Wayne
Gruber, Nancy
and
Rurak, Dan
2002.
Effect of Maternal Fluoxetine Administration on Uterine Blood Flow, Fetal Blood Gas Status, and Growth.
Pediatric Research,
Vol. 51,
Issue. 4,
p.
433.
McElhatton, Patricia
2002.
Teratogenic drugs ??? part 1.
Adverse Drug Reaction Bulletin,
Vol. &NA;,
Issue. 213,
p.
815.
Ruhé, H. G.
2003.
Farmacotherapie bij unipolaire depressiefarmacotherapie stemmingsstoornissen unipolaire.
Bijblijven,
Vol. 19,
Issue. 9,
p.
356.
Goodrum, Linda A.
Hankins, Gary D.V.
Jermain, Donna
and
Chanaud, Cheryl M.
2003.
Conference Report: Complex Clinical, Legal, and Ethical Issues of Pregnant and Postpartum Women as Subjects in Clinical Trials.
Journal of Women's Health,
Vol. 12,
Issue. 9,
p.
857.
Cott, A. D.
and
Wisner, K. L.
2003.
Psychiatric disorders during pregnancy.
International Review of Psychiatry,
Vol. 15,
Issue. 3,
p.
217.
Hasler, William L
2003.
The irritable bowel syndrome during pregnancy.
Gastroenterology Clinics of North America,
Vol. 32,
Issue. 1,
p.
385.
Bennett, Heather A
Einarson, Adrienne
Taddio, Anna
Koren, Gideon
and
Einarson, Thomas R
2004.
Depression during Pregnancy.
Clinical Drug Investigation,
Vol. 24,
Issue. 3,
p.
157.
Hines, Ronald N.
Adams, Jane
Buck, Germaine M.
Faber, Willem
Holson, Joseph F.
Jacobson, Sandra W.
Keszler, Martin
McMartin, Kenneth
Segraves, Robert Taylor
Singer, Lynn T.
Sipes, I. Glenn
and
Williams, Paige L.
2004.
NTP‐CERHR Expert Panel Report on the reproductive and developmental toxicity of fluoxetine.
Birth Defects Research Part B: Developmental and Reproductive Toxicology,
Vol. 71,
Issue. 4,
p.
193.
Kohen, Dora
2004.
Psychotropic medication in pregnancy.
Advances in Psychiatric Treatment,
Vol. 10,
Issue. 1,
p.
59.
Eberhard-Gran, Malin
Eskild, Anne
and
Opjordsmoen, Stein
2005.
Treating Mood Disorders During Pregnancy.
Drug Safety,
Vol. 28,
Issue. 8,
p.
695.
Lattimore, Keri A
Donn, Steven M
Kaciroti, Niko
Kemper, Alex R
Neal, Charles R
and
Vazquez, Delia M
2005.
Selective Serotonin Reuptake Inhibitor (SSRI) Use during Pregnancy and Effects on the Fetus and Newborn: A Meta-Analysis.
Journal of Perinatology,
Vol. 25,
Issue. 9,
p.
595.